BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30373845)

  • 21. Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel.
    Hohla F; Schally AV; Szepeshazi K; Varga JL; Buchholz S; Köster F; Heinrich E; Halmos G; Rick FG; Kannadka C; Datz C; Kanashiro CA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14513-8. PubMed ID: 16983095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.
    Busto R; Schally AV; Varga JL; Garcia-Fernandez MO; Groot K; Armatis P; Szepeshazi K
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11866-71. PubMed ID: 12186980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
    Garcia-Fernandez MO; Schally AV; Varga JL; Groot K; Busto R
    Breast Cancer Res Treat; 2003 Jan; 77(1):15-26. PubMed ID: 12602901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of cardiac and systemic function in old mice by agonist of growth hormone-releasing hormone.
    Xiang P; Jing W; Lin Y; Liu Q; Shen J; Hu X; Chen J; Cai R; Hare JM; Zhu W; Schally AV; Yu H
    J Cell Physiol; 2021 Dec; 236(12):8197-8207. PubMed ID: 34224586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.
    Cai R; Zhang X; Wang H; Cui T; Halmos G; Sha W; He J; Popovics P; Vidaurre I; Zhang C; Mirsaeidi M; Schally AV
    Peptides; 2022 Apr; 150():170716. PubMed ID: 34952135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer.
    Muñoz-Moreno L; Arenas MI; Carmena MJ; Schally AV; Sánchez-Chapado M; Prieto JC; Bajo AM
    Oncotarget; 2016 Aug; 7(32):52195-52206. PubMed ID: 27448980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
    Köster F; Engel JB; Schally AV; Hönig A; Schröer A; Seitz S; Hohla F; Ortmann O; Diedrich K; Buchholz S
    Breast Cancer Res Treat; 2009 Jul; 116(2):273-9. PubMed ID: 18629632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.
    Muñoz-Moreno L; Arenas MI; Carmena MJ; Schally AV; Prieto JC; Bajo AM
    Invest New Drugs; 2014 Oct; 32(5):871-82. PubMed ID: 25000999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone.
    Jimenez JJ; DelCanto GM; Popovics P; Perez A; Vila Granda A; Vidaurre I; Cai RZ; Rick FG; Swords RT; Schally AV
    Br J Haematol; 2018 May; 181(4):476-485. PubMed ID: 29663325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer.
    Papadia A; Schally AV; Halmos G; Varga JL; Seitz S; Buchholz S; Rick F; Zarandi M; Bellyei S; Treszl A; Szalontay L; Lucci JA
    Horm Metab Res; 2011 Oct; 43(11):816-20. PubMed ID: 22009378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
    Schally AV; Varga JL; Engel JB
    Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):33-43. PubMed ID: 18084344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
    Mezey G; Treszl A; Schally AV; Block NL; Vízkeleti L; Juhász A; Klekner A; Nagy J; Balázs M; Halmos G; Bognár L
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1641-9. PubMed ID: 24878932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells.
    Chu WK; Law KS; Chan SO; Yam JC; Chen LJ; Zhang H; Cheung HS; Block NL; Schally AV; Pang CP
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14396-14401. PubMed ID: 27911838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells.
    Ziegler CG; Ullrich M; Schally AV; Bergmann R; Pietzsch J; Gebauer L; Gondek K; Qin N; Pacak K; Ehrhart-Bornstein M; Eisenhofer G; Bornstein SR
    Mol Cell Endocrinol; 2013 May; 371(1-2):189-94. PubMed ID: 23267837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer.
    Muñoz-Moreno L; Schally AV; Prieto JC; Carmena MJ; Bajo AM
    Prostate; 2018 Sep; 78(12):915-926. PubMed ID: 29748961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.
    Stangelberger A; Schally AV; Zarandi M; Heinrich E; Groot K; Havt A; Kanashiro CA; Varga JL; Halmos G
    Prostate; 2007 Sep; 67(12):1339-53. PubMed ID: 17624923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury.
    Cen LP; Ng TK; Liang JJ; Xu C; Zhuang X; Liu YF; Chen SL; Xu Y; Yang Q; Yuan XL; Qin YJ; Chan SO; Chen H; Zhang M; Schally AV; Pang CP
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.
    Stangelberger A; Schally AV; Rick FG; Varga JL; Baker B; Zarandi M; Halmos G
    Prostate; 2012 Apr; 72(5):555-65. PubMed ID: 21796649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.
    Florea V; Majid SS; Kanashiro-Takeuchi RM; Cai RZ; Block NL; Schally AV; Hare JM; Rodrigues CO
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17260-5. PubMed ID: 25404316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.